- Details
- Description
Packaging Size:
1Bottle/Box
Strength:
100mg/10ml
Composition:
Ripertamab
Treatment:
Diffuse large B lymphoma,DLBCL
Form:
Injection
Brand:
安平希
Quantity Unit:
100mg(10ml)*1Bottle/Box
Manufacturer:
Sinocelltech Group Ltd.,China
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb.
- Ripertamab sold under the brand name 安平希® in china.
Ripertamab approval from China’s NMPA to treat patients with CD20-positive diffuse large B-cell lymphoma. The country’s first homegrown anti-CD20 therapy, ripertamab has been shown to have similar efficacy to global blockbuster rituximab but with a superior safety profile.
